Cargando…
Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice
Fibroblast growth factor (FGF) 21 is an endocrine factor that normalizes glucose homeostasis and reduces insulin resistance in diabetes. Although the pancreas is an FGF21 target organ, its role in pancreatic islets remains obscure. This study aimed to elucidate the physiological role of FGF21 in pan...
Autores principales: | So, W Y, Cheng, Q, Xu, A, Lam, K S L, Leung, P S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385948/ https://www.ncbi.nlm.nih.gov/pubmed/25811804 http://dx.doi.org/10.1038/cddis.2015.80 |
Ejemplares similares
-
High Glucose Represses β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets: Involvement of Peroxisome Proliferator–Activated Receptor γ Signaling
por: So, Wing Yan, et al.
Publicado: (2013) -
The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus
por: Leung, Po Sing
Publicado: (2016) -
Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas
por: Singhal, Garima, et al.
Publicado: (2016) -
Fibroblast Growth Factor 21 Stimulates Pancreatic Islet Autophagy via Inhibition of AMPK-mTOR Signaling
por: Cheng, Sam Tsz Wai, et al.
Publicado: (2019) -
Alcohol ingestion induces pancreatic islet dysfunction and apoptosis via mediation of FGF21 resistance
por: Yang, Bao Chen, et al.
Publicado: (2020)